Understand the source comparison
Peptides for Autoimmune Conditions Research: Peptide Type Comparison
Choosing the right peptide for autoimmune research depends on the immune pathway being investigated. Thymic peptides restore regulatory T-cell function. Anti-inflammatory peptides block cytokine signaling. Regenerative peptides repair tissue damage. The table
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Choosing the right peptide for autoimmune research depends on the immune pathway being investigated. Thymic peptides restore regulatory T-cell function. Anti-inflammatory peptides block cytokine signaling. Regenerative peptides repair tissue damage. The table below compares the primary mechanisms, administration routes, and research applications of the most frequently investigated peptides.
- Thymalin
- Upregulates CD4+CD25+Foxp3+ regulatory T-cells; restores thymic output and peripheral Treg expansion
- Subcutaneous injection
- Systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis. Conditions driven by Treg dysfunction
- Gold standard for Treg restoration studies; most direct thymic hormone replacement available
- Thymosin Alpha-1
- TLR9 agonist; modulates dendritic cell maturation and shifts cytokine profile from Th1/Th17 to Th2/Treg
- Rheumatoid arthritis, psoriasis, autoimmune hepatitis. Conditions with Th1/Th17 dominance
- Clinical trial data strongest among immunomodulatory peptides; FDA-approved in multiple countries for viral hepatitis
- KPV
- Inhibits NF-κB translocation, blocking transcription of TNF-α, IL-6, IL-1β
- Oral administration (survives gastric transit)
- Inflammatory bowel disease (Crohn's, ulcerative colitis). Localized intestinal inflammation
- Rare oral-bioavailable peptide; ideal for localized gut inflammation without systemic immunosuppression
- BPC-157
- Activates VEGF receptor-2 and eNOS pathways; promotes angiogenesis and endothelial repair
- Subcutaneous or oral
- Tissue repair in autoimmune-damaged organs (joints, kidneys, intestinal fistulas)
- Best evidence for vascular and mucosal healing; complements immunomodulators in combination protocols
- TB-500
- Upregulates actin polymerization; enables cell migration and extracellular matrix remodeling
- Tissue regeneration in chronic autoimmune damage (joint erosion, renal fibrosis)
- Superior for structural repair; particularly valuable in post-inflammatory remodeling phases
- Ipamorelin/MK-677
- Stimulates endogenous growth hormone release; counteracts corticosteroid-induced muscle wasting and bone loss
- Subcutaneous (Ipamorelin), oral (MK-677)
- Metabolic dysfunction in chronic corticosteroid therapy
- Not autoimmune-specific but essential for managing long-term steroid side effects in research cohorts